Will Teladoc stock see a boost with Q1 results in focus?

Teladoc Health (NYSE:TDOC) is scheduled to announce Q1 earnings results on Wednesday, April 26th, after market close.

The consensus EPS Estimate is -$0.49 (+98.8% Y/Y) and the consensus Revenue Estimate is $618.24M (+9.3% Y/Y).

Over the last 1 year, TDOC has beaten EPS estimates 75% of the time and has beaten revenue estimates 88% of the time.

Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 0 upward revisions and 17 downward.

The virtual healthcare provider's stock fell -6.80% on Feb. 23, the day after the company's Q4 results post market Feb. 22. The company's Q4 GAAP EPS missed estimates, while fiscal 2023 revenue estimate was lower than consensus.

Following earnings, the stock may have tumbled but SVB Securities was bullish on Teladoc as it upgraded the shares to outperform from market perform noting that TDOC was poised to meet its fiscal 2023 outlook after a spate of poor performance.

YTD, Teladoc shares have risen ~22%, compared to ~7% for the broad market indicator SP500, see chart here. The SA Quant Rating on TDOC is Hold, and the average Wall Street Analysts' Rating agrees with a Hold rating of its own.

Earlier in April, the shares also got a boost after the company announced that it is launching provider-based care for weight management and prediabetes.

Other News: Teladoc-owned BetterHelp settled with FTC over allegations of sharing customers' sensitive health data with third parties for marketing without their consent.